Skip to main content
Top
Published in: Acta Diabetologica 4/2009

01-12-2009 | Original Article

How often do we ask about erectile dysfunction in the diabetes review clinic?

Development of a neuropathy screening tool

Authors: Paul S. Grant, David Lipscomb

Published in: Acta Diabetologica | Issue 4/2009

Login to get access

Abstract

Diabetic neuropathy is a significant complication of chronic diabetes. We wished to discover whether we were successfully identifying patients who had developed neuropathic problems. Specifically, Diabetologists are traditionally poor at asking about erectile dysfunction (ED) and patients themselves are not always forthcoming as it an embarrassing medical problem. We targeted all patients attending diabetes review clinics over a 4-month period in two hospitals and asked them to complete an anonymous, self-reported questionnaire after their consultation with the diabetologist or diabetes specialist nurse. Whilst most aspects of diabetic neuropathy are routinely screened for in the diabetes clinic we found that the neuropathic symptoms of both ED and gastroparesis were not commonly enquired about, and that erectile failure was found to be more prevalent than previously. Diabetologists need to be more thorough in their assessment of diabetic neuropathy. This is especially of import with regards to ED because we often shy away from enquiring into such a personal area and male patients rarely highlight the issue due to embarrassment. Our post consultation questionnaire has now been modified to form a useful preconsultation neuropathy screening tool and this is undergoing validation.
Appendix
Available only for authorised users
Literature
2.
go back to reference Moghtaderi A, Bakhshipour A, Rashidi H (2006) Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 108(5):477–481CrossRefPubMed Moghtaderi A, Bakhshipour A, Rashidi H (2006) Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 108(5):477–481CrossRefPubMed
3.
go back to reference Feldman EL, Stevens MJ (1994) Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci 21(4):S3–S7PubMed Feldman EL, Stevens MJ (1994) Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci 21(4):S3–S7PubMed
4.
go back to reference Wellmer A, Sharief MK, Knowles CH, Misra VP, Kopelman P, Ralph D, Anand P (1999) Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction. BJU Int 83(1):66–70CrossRefPubMed Wellmer A, Sharief MK, Knowles CH, Misra VP, Kopelman P, Ralph D, Anand P (1999) Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction. BJU Int 83(1):66–70CrossRefPubMed
5.
go back to reference Cleveringa FG, Meulenberg MG, Gorter KJ, van den Donk M, Rutten GE (2008) The association between erectile dysfunction and cardiovascular risk in men with type 2 diabetes in primary care: it is a matter of age. J Diabetes Complications [Epub ahead of print] Cleveringa FG, Meulenberg MG, Gorter KJ, van den Donk M, Rutten GE (2008) The association between erectile dysfunction and cardiovascular risk in men with type 2 diabetes in primary care: it is a matter of age. J Diabetes Complications [Epub ahead of print]
6.
go back to reference Sivalingam S, Hashim H, Schwaibold H (2006) An overview of the diagnosis and treatment of erectile dysfunction. Drugs 66(18):2339–2355CrossRefPubMed Sivalingam S, Hashim H, Schwaibold H (2006) An overview of the diagnosis and treatment of erectile dysfunction. Drugs 66(18):2339–2355CrossRefPubMed
7.
go back to reference National Institute for Health and Clinical Excellence. CG15 type 1 diabetes in adults: full guideline, references and appendices, 2004 National Institute for Health and Clinical Excellence. CG15 type 1 diabetes in adults: full guideline, references and appendices, 2004
8.
go back to reference Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS (2007) Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8:S50–S62CrossRefPubMed Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS (2007) Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8:S50–S62CrossRefPubMed
9.
go back to reference Grant P, Hogan D (2009) The perfect diabetes review. Stud BMJ (in press) Grant P, Hogan D (2009) The perfect diabetes review. Stud BMJ (in press)
10.
go back to reference Bryant W, Greenfield JR, Chisholm DJ, Campbell LV (2006) Diabetes guidelines: easier to preach than to practise? Med J Aust 185(6):305–309PubMed Bryant W, Greenfield JR, Chisholm DJ, Campbell LV (2006) Diabetes guidelines: easier to preach than to practise? Med J Aust 185(6):305–309PubMed
12.
go back to reference Punkkinen J, Färkkilä M, Mätzke S, Korppi-Tommola T, Sane T, Piirilä P, Koskenpato J (2008) Upper abdominal symptoms in patients with type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet Med 25(5):570–577CrossRefPubMed Punkkinen J, Färkkilä M, Mätzke S, Korppi-Tommola T, Sane T, Piirilä P, Koskenpato J (2008) Upper abdominal symptoms in patients with type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet Med 25(5):570–577CrossRefPubMed
13.
go back to reference Hasler WL (2008) Gastroparesis—current concepts and considerations. Medscape J Med 10(1):16PubMed Hasler WL (2008) Gastroparesis—current concepts and considerations. Medscape J Med 10(1):16PubMed
14.
go back to reference Glasgow RE, Peeples M, Skovlund SE (2008) Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabetes Care 31(5):1046–1050CrossRefPubMed Glasgow RE, Peeples M, Skovlund SE (2008) Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabetes Care 31(5):1046–1050CrossRefPubMed
15.
go back to reference Barth JH, Marshall SM, Watson ID (2008) Consensus meeting on reporting glycated haemoglobin (HbA1c) and estimated average glucose (eAG) in the UK: report to the National Director for Diabetes, Department of Health. Diabet Med 25(4):381–382CrossRefPubMed Barth JH, Marshall SM, Watson ID (2008) Consensus meeting on reporting glycated haemoglobin (HbA1c) and estimated average glucose (eAG) in the UK: report to the National Director for Diabetes, Department of Health. Diabet Med 25(4):381–382CrossRefPubMed
16.
go back to reference Boulton AJ (1998) Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. European Association for the Study of Diabetes, Neurodiab. Diabetes Metab 24(3):55–65PubMed Boulton AJ (1998) Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. European Association for the Study of Diabetes, Neurodiab. Diabetes Metab 24(3):55–65PubMed
Metadata
Title
How often do we ask about erectile dysfunction in the diabetes review clinic?
Development of a neuropathy screening tool
Authors
Paul S. Grant
David Lipscomb
Publication date
01-12-2009
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2009
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0084-1

Other articles of this Issue 4/2009

Acta Diabetologica 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.